BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 37735413)

  • 1. Epigenetic meets metabolism: novel vulnerabilities to fight cancer.
    Scumaci D; Zheng Q
    Cell Commun Signal; 2023 Sep; 21(1):249. PubMed ID: 37735413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (De)Toxifying the Epigenetic Code.
    Zheng Q; Prescott NA; Maksimovic I; David Y
    Chem Res Toxicol; 2019 May; 32(5):796-807. PubMed ID: 30839196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of non-enzymatic glycosylation in the epigenetics of cancer.
    Rehman S; Aatif M; Rafi Z; Khan MY; Shahab U; Ahmad S; Farhan M
    Semin Cancer Biol; 2022 Aug; 83():543-555. PubMed ID: 33276090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-enzymatic covalent modifications: a new link between metabolism and epigenetics.
    Zheng Q; Maksimovic I; Upad A; David Y
    Protein Cell; 2020 Jun; 11(6):401-416. PubMed ID: 32356279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chemical field guide to histone nonenzymatic modifications.
    Faulkner S; Maksimovic I; David Y
    Curr Opin Chem Biol; 2021 Aug; 63():180-187. PubMed ID: 34157651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DJ-1 Proteoforms in Breast Cancer Cells: The Escape of Metabolic Epigenetic Misregulation.
    Scumaci D; Olivo E; Fiumara CV; La Chimia M; De Angelis MT; Mauro S; Costa G; Ambrosio FA; Alcaro S; Agosti V; Costanzo FS; Cuda G
    Cells; 2020 Aug; 9(9):. PubMed ID: 32858971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
    Komar D; Juszczynski P
    Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible histone glycation is associated with disease-related changes in chromatin architecture.
    Zheng Q; Omans ND; Leicher R; Osunsade A; Agustinus AS; Finkin-Groner E; D'Ambrosio H; Liu B; Chandarlapaty S; Liu S; David Y
    Nat Commun; 2019 Mar; 10(1):1289. PubMed ID: 30894531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific regulation of epigenome landscape by metabolic enzymes and metabolites.
    Yu X; Li S
    Biol Rev Camb Philos Soc; 2024 Jun; 99(3):878-900. PubMed ID: 38174803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming and epigenetic modifications on the path to cancer.
    Sun L; Zhang H; Gao P
    Protein Cell; 2022 Dec; 13(12):877-919. PubMed ID: 34050894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging histone glycation for cancer diagnostics and therapeutics.
    Knörlein A; Xiao Y; David Y
    Trends Cancer; 2023 May; 9(5):410-420. PubMed ID: 36804508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordination of cross-talk between metabolism and epigenetic regulation by the SIN3 complex.
    Soukar I; Amarasinghe A; Pile LA
    Enzymes; 2023; 53():33-68. PubMed ID: 37748836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array.
    Wang X; Shi Z; Lu HY; Kim JJ; Bu W; Villalobos JA; Perera DN; Jung SY; Wang T; Grimm SL; Taylor BC; Rajapakshe K; Park H; Wulfkuhle J; Young NL; Li Y; Coarfa C; Edwards DP; Huang S
    J Proteomics; 2022 Jun; 262():104596. PubMed ID: 35489683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenomic and enhancer dysregulation in uterine leiomyomas.
    Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
    Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone onco-modifications.
    Füllgrabe J; Kavanagh E; Joseph B
    Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expanding Constellation of Histone Post-Translational Modifications in the Epigenetic Landscape.
    Cavalieri V
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone modification therapy of cancer.
    Biancotto C; Frigè G; Minucci S
    Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.